Antiviral triple therapy with boceprevir in a chronic hepatitis C haemodialysis patient awaiting kidney re-transplantation

Digestive and Liver Disease

Volumn 46, Issue 1, 2014, Pages 88-89

  Knapstein, Johanna ^a   Galle, Peter R ^a   Zimmermann, Tim ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BOCEPREVIR; ERYTHROPOIETIN; HEMOGLOBIN; METHYLPREDNISOLONE; METOPROLOL; PEGINTERFERON; RIBAVIRIN; TORASEMIDE;

ADULT; ANEMIA; ANTIVIRAL THERAPY; BLOOD TRANSFUSION; CASE REPORT; DIARRHEA; DRUG DOSE REDUCTION; DYSGEUSIA; END STAGE RENAL DISEASE; ERYTHROCYTE COUNT; HEMOGLOBIN BLOOD LEVEL; HEPATITIS C; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LETTER; LEUKOCYTE COUNT; MALE; PRIORITY JOURNAL; THROMBOCYTE COUNT; TREATMENT DURATION; VIRUS LOAD;

ADULT; ANTIVIRAL AGENTS; DRUG CARRIERS; DRUG THERAPY, COMBINATION; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-ALPHA; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; METHYLPREDNISOLONE; POLYETHYLENE GLYCOLS; PROLINE; RENAL DIALYSIS; RIBAVIRIN; TREATMENT OUTCOME; VIRAL LOAD;

EID: 84892364359     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2013.08.133     Document Type: Letter

References (5)

1. Berenguer M. Treatment of chronic hepatitis C in hemodialysis patients. Hepatology 2008, 48:1690-1699.
2. Fabrizi F., Dixit V., Martin P., et al. Combined antiviral therapy of hepatitis C virus in dialysis patients: meta-analysis of clinical trials. Journal of Viral Hepatitis 2011, 18:263-269.
3. Kwo P.Y., Lawitz E.J., McCone J., et al. Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peg-interferon alpha-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicenter phase 2 trial. Lancet 2011, 376:705-716.
4. Jacobson I.M., McHutchinson J.G., Dusheiko G., et al. Telaprevir for previously untreated chronic hepatitis C virus infection. New England Journal of Medicine 2011, 364:2405-2416.
5. Dumortier J., Guillaud O., Gagnieu M.C., et al. Anti-viral triple therapy with telaprevir in haemodialysed patients: is it feasible. Journal of Clinical Virology 2013, 56:146-149.